bioRxiv / medRxivopen access
Health-related quality of life in mild-moderate patchy alopecia areata: Results from the first controlled Phase 2 clinical trial in this population with STS01 (dithranol/ProSilic) and challenges for the future
dermatology
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 151600
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.